Emil Adolf von Behring
From Wikipedia, the free encyclopedia
 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (March 2009) |
| Emil Adolf von Behring | |
|---|---|
 Emil Adolf von Behring
|
|
| Born | 15 March 1854 Hansdorf |
| Died | 31 March 1917 (aged 63) Marburg, Hesse-Nassau |
| Nationality | Germany |
| Fields | Physiology, immunology |
| Known for | Diphtheria vaccine |
| Notable awards | Nobel Prize in Physiology or Medicine (1901) |
Emil Adolf von Behring (15 March 1854 – 31 March 1917) was a German physiologist who received the 1901 Nobel Prize in Physiology or Medicine.
Contents |
[edit] Biography
Behring was born Adolf Emil Behring in Hansdorf (now Ławice, Iława County), Kreis Rosenberg, Province of Prussia.
Between 1874 and 1878 he studied medicine at the Akademie für das militärärztliche Bildungswesen, Berlin. He was mainly a military doctor and then became Professor of Hygienics within the Faculty of Medicine at the University of Marburg (against the initial strenuous opposition of the faculty council), a position he would hold for the rest of his life.
Behring was the discoverer of diphtheria antitoxin and attained a great reputation by that means and by his contributions to the study of immunity. He won the first Nobel Prize in Physiology or Medicine in 1901 for developing a serum therapy against diphtheria (this was worked on with Emile Roux) and tetanus. The former had been a scourge of the population, especially children, whereas the other was a leading cause of death in wars, killing the wounded. At the International Tuberculosis Congress in 1905 he announced that he had discovered "a substance proceeding from the virus of tuberculosis." This substance, which he designated "T C", plays the important part in the immunizing action of Professor Behring's "bovivaccine", which prevents bovine tuberculosis.
Behring died at Marburg, Hessen-Nassau, on 31 March 1917. His name survives in Dade Behring, the world's largest company dedicated solely to clinical diagnostics, in CSL Behring a manufacturer of plasma-derived biotherapies, in Behringwerke AG in Marburg, in Novartis Behring and in the Emil von Behring Prize of the University of Marburg, the highest endowed medicine award in Germany.
His Nobel Prize medal, is now kept on display at the International Red Cross and Red Crescent Museum in Geneva.
[edit] Publications
- Die Blutserumtherapie (1892)
- Die Geschichte der Diphtherie (1893)
- Bekämpfung der Infektionskrankheiten (1894)
- Beiträge zur experimentellen Therapie (1906)
[edit] See also
[edit] References
 |
This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. Please improve this article by introducing more precise citations where appropriate. (March 2009) |
- Karoline Grundmann (3 December 2001). "Emil von Behring: The founder of serum therapy". The Nobel Foundation. http://nobelprize.org/nobel_prizes/medicine/articles/behring/index.html. Retrieved 2008-07-21.
- This article incorporates text from an edition of the New International Encyclopedia that is in the public domain.
[edit] External links
 |
Wikimedia Commons has media related to: Emil Adolf von Behring |
|
||||||||
